159 related articles for article (PubMed ID: 25917886)
1. Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia.
Micoulaud-Franchi JA; Faugere M; Boyer L; Cermolacce M; Richieri R; Faget C; Philip P; Vion-Dury J; Lancon C
Psychoneuroendocrinology; 2015 Jul; 57():125-33. PubMed ID: 25917886
[TBL] [Abstract][Full Text] [Related]
2. Sensory gating deficits and impaired quality of life in patients with schizophrenia: A preliminary study.
Micoulaud-Franchi JA; Faugere M; Boyer L; Cermolacce M; Fond G; Richieri R; Vion-Dury J; Lancon C
Psychiatr Danub; 2016 Sep; 28(3):225-233. PubMed ID: 27658831
[TBL] [Abstract][Full Text] [Related]
3. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
[TBL] [Abstract][Full Text] [Related]
5. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
[TBL] [Abstract][Full Text] [Related]
6. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
[TBL] [Abstract][Full Text] [Related]
7. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
[TBL] [Abstract][Full Text] [Related]
8. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
[TBL] [Abstract][Full Text] [Related]
9. P50 gating in deficit and nondeficit schizophrenia.
Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
[TBL] [Abstract][Full Text] [Related]
10. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.
Hamilton HK; Williams TJ; Ventura J; Jasperse LJ; Owens EM; Miller GA; Subotnik KL; Nuechterlein KH; Yee CM
Am J Psychiatry; 2018 Mar; 175(3):275-283. PubMed ID: 29202656
[TBL] [Abstract][Full Text] [Related]
12. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
[TBL] [Abstract][Full Text] [Related]
13. Auditory sensory processing deficits in sensory gating and mismatch negativity-like responses in the social isolation rat model of schizophrenia.
Witten L; Oranje B; Mørk A; Steiniger-Brach B; Glenthøj BY; Bastlund JF
Behav Brain Res; 2014 Jun; 266():85-93. PubMed ID: 24613239
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MÁ; Soria C; Arango C
Schizophr Res; 2013 Jan; 143(1):102-6. PubMed ID: 23148896
[TBL] [Abstract][Full Text] [Related]
15. [Sensory gating P50 in schizophrenic patients with and without homicide].
Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
[TBL] [Abstract][Full Text] [Related]
16. Chronic effects of cannabis on sensory gating.
Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N
Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289
[TBL] [Abstract][Full Text] [Related]
17. Sensory and sensorimotor gating in adult attention-deficit/hyperactivity disorder (ADHD).
Holstein DH; Vollenweider FX; Geyer MA; Csomor PA; Belser N; Eich D
Psychiatry Res; 2013 Jan; 205(1-2):117-26. PubMed ID: 23017654
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic effects on auditory sensory gating in schizophrenia patients.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483
[TBL] [Abstract][Full Text] [Related]
19. Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
Knott V; de la Salle S; Smith D; Phillipe T; Dort H; Choueiry J; Impey D
J Psychopharmacol; 2013 Sep; 27(9):790-800. PubMed ID: 23744798
[TBL] [Abstract][Full Text] [Related]
20. P50 gating at acute and post-acute phases of first-episode schizophrenia.
Devrim-Uçok M; Keskin-Ergen HY; Uçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
